Document:

exv10w2

Exhibit 10.2

REGISTRATION RIGHTS AGREEMENT

          This REGISTRATION RIGHTS AGREEMENT (“Agreement”), dated as of January  , 2010, is
made by and among JLL Partners Fund V, L.P., a Delaware limited partnership (“JLL Fund V”),
and Warburg Pincus Private Equity IX, L.P., a Delaware limited partnership (“Warburg
Pincus”) (each of JLL Fund V and Warburg Pincus, an “Investor,” and collectively, the
“Investors”), and Builders FirstSource, Inc., a Delaware corporation (the
“Company”).

W I T N E S S E T H

          WHEREAS, upon the consummation of the Recapitalization (as defined below), JLL Fund V
beneficially owns 24,344,584 shares of common stock, par value $0.01 per share, of the Company
(“Common Stock”) and Warburg Pincus beneficially owns 24,447,425 shares of Common Stock;
and

          WHEREAS, as part of the Recapitalization, the Company distributed, at no charge, to each
holder of record as of the close of business on December 14, 2009, of shares of Common Stock
transferable rights (“Rights”) to subscribe for and purchase at a price of $3.50 per share
(as adjusted for any stock split, combination, reorganization, recapitalization, stock dividend,
stock distribution or similar event, the “Subscription Price”) up to its pro rata portion
of 58,571,428 shares of Common Stock (the “Offered Shares”) such that, if the Rights were
exercised in full, the Company would receive gross proceeds of $205.0 million (the “Rights
Offering”); and

          WHEREAS, as part of the Recapitalization, the Company also agreed with certain accredited
holders of the outstanding Second Priority Senior Secured Floating Rate Notes due 2012 of the
Company (the “Notes”) to exchange, at par, such holders’ Notes (i) for new second lien debt
securities (“New Notes”) and cash from a portion of the proceeds of the Rights Offering in
transactions exempt from the registration requirements of the Securities Act of 1933, as amended
(the “Securities Act”), pursuant to Section 4(2) thereunder and (ii) under certain
circumstances, to provide holders of outstanding Notes the right to exchange outstanding Notes for
shares of Common Stock at an exchange price equal to the Subscription Price in transactions exempt
from the registration requirements of the Securities Act, substantially on the terms set forth in
that certain Support Agreement, dated as of October 23, 2009 (as amended, the “Support
Agreement”), between the Company and certain holders of outstanding Notes signatory thereto
(collectively, the “Debt Exchange” and, together with the Rights Offering and the
transactions contemplated by the Support Agreement and the Investment Agreement (as defined below),
the “Recapitalization”); and

          WHEREAS, pursuant to that certain Investment Agreement, dated as of October 23, 2009 (as
amended, the “Investment Agreement”), upon the terms and subject to the satisfaction or
waiver of the conditions described therein, (i) to the extent that the gross proceeds of the Rights
Offering were less than $75.0 million, the Company had the right to require the Investors to
purchase, upon expiration of the Rights Offering, at the Subscription Price, a number

 

 

of Offered Shares not subscribed for and purchased by holders of Rights upon exercise thereof
under the basic subscription privilege and over-subscription privilege such that the total gross
proceeds of the Rights Offering equal $75.0 million; and (ii) to the extent that the Rights
Offering was not fully subscribed, the Investors agreed to exchange the Notes held indirectly by
such Investors for shares of Common Stock at an exchange price equal to the Subscription Price, to
the extent of such deficiency and subject to the rights of other holders of Notes that participate
in such exchange; and

          WHEREAS, in consideration of the Investors’ commitment to purchase Common Stock and exchange
Notes pursuant to, upon the terms, and subject to the conditions set forth in the Investment
Agreement, the Company has agreed, among other things, to provide registration rights to the
Investors with respect to all shares of Common Stock owned or hereinafter acquired by the Investors
and their respective Affiliates (as defined below).

          NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and
for good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree
as follows:

ARTICLE I

Certain Definitions

          For purposes of this Agreement, the following terms shall have the following meanings:

               (a) The term “Affiliate” means a Person that directly, or indirectly through one or
more intermediaries, controls or is controlled by, or is under common control with, the Person
specified, the term “control” (including the terms “controlling,” “controlled by,” and “under
common control with”) meaning the possession, direct or indirect, of the power to direct or cause
the direction of the management and policies of a Person, whether through the ownership of voting
securities, by contract, or otherwise

               (b) The term “Board” means the Board of Directors of the Company.

               (c) The term “Commission” means the United States Securities and Exchange Commission
or any successor agency.

               (d) The term “Exchange Act” means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

               (e) The term “Fair Market Value” means the fair market value per share of the Common
Stock as of a particular date determined as: (i) the average closing sales price per share of the
Common Stock on the national securities exchange on which the Common Stock is principally traded,
for the last five preceding dates on which there was a sale of such Common Stock on such exchange;
or (ii) if the shares of Common Stock are then traded in an over-the-counter market, the average of
the closing bid and asked prices for the shares of Common Stock in such over-the-counter market for
the last five preceding dates on which there was a sale of such Common Stock in such market; or
(iii) if the shares of Common Stock are not

2

 

then listed on a national securities exchange or traded in an over-the-counter market, such
value as the Board, in its good faith judgment, shall determine.

               (f) The term “Person” means any individual, firm, corporation, partnership, limited
liability company, trust, or other entity and shall include any successor (by merger or otherwise)
of such entity.

               (g) The term “Public Offering” means a public offering of equity securities of the
Company pursuant to an effective registration statement under the Securities Act (other than (i) a
registration statement filed under Regulation A or on Form S-4 or any successor form or (ii) a
registration statement filed on Form S-8 or any successor form).

               (h) The term “Registrable Securities” means the Shares, provided, however, that as to
any particular Registrable Securities, such securities shall cease to be Registrable Securities
when (i) a registration statement registering such securities under the Securities Act has been
declared effective and such securities have been sold or otherwise transferred by the holder
thereof pursuant to such effective registration statement; or (ii) such securities are sold in
accordance with Rule 144 (or any successor provision) promulgated under the Securities Act; or
(iii) such securities are transferred under circumstances in which any legend borne by the
certificates for such securities or noted in the Company’s stock book and transfer records relating
to restrictions on transferability thereof, under the Securities Act or otherwise, is removed by
the Company.

               (i) The term “Requisite Amount” means such number of shares of Registrable Securities
having an aggregate Fair Market Value of $125,000.

               (j) The term “Shares” means (i) all shares of Common Stock owned immediately following
the consummation of the Recapitalization by JLL Fund V and Warburg Pincus and their respective
Affiliates, including, without limitation, Building Products, LLC and JWP LLC (including, without
limitation, shares of Common Stock acquired by Building Products, LLC and JWP LLC in the
Recapitalization); and (ii) additional shares of Common Stock acquired by JLL Fund V and Warburg
Pincus and their respective Affiliates, including, without limitation, Building Products, LLC and
JWP LLC, in any manner after the date hereof.

ARTICLE II

Representations and Warranties

          Section 2.01
Representations and Warranties of the Investors. Each Investor individually
represents and warrants to the Company the following:

               (a) Such Investor has the requisite power and authority to enter into, execute, and deliver
this Agreement and to consummate the transactions contemplated hereby in accordance with the terms
hereof. The execution and delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary action on the part of such Investor;
and

3

 

               (b) This Agreement has been duly and validly executed and delivered by such Investor and is,
assuming due execution and delivery hereof by the Company and that the Company has full legal power
and right to enter into this Agreement, a valid and binding obligation of such Investor,
enforceable against such Investor in accordance with its terms, except as enforcement thereof may
be limited by the effect of bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or similar laws affecting the enforcement of creditors’ rights generally, and subject
to principles of equity and public policy; and

               (c) The Investor understands and acknowledges that, until such time as the same is no longer
required under any applicable requirements of the Securities Act and the rules and regulations
thereunder or applicable state securities laws, the Company and its transfer agent shall make such
notation in the stock book and transfer records of the Company or, in the case of certificated
Shares, imprint legends as may be necessary to record that the transfer of the Shares must be
registered under the Securities Act (subject to any applicable exemptions).

          Section Section 2.02 Representations and Warranties of the Company. The Company represents and
warrants to each of the Investors the following:

               (a) The Company is a corporation duly organized and validly existing in good standing under
the laws of the State of Delaware and has the requisite corporate power and authority to enter
into, execute, and deliver this Agreement and to consummate the transactions contemplated hereby in
accordance with the terms hereof. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby have been duly authorized by all necessary
corporate action on the part of the Company; and

               (b) This Agreement has been duly and validly executed and delivered by the Company and is,
assuming due execution and delivery hereof by each of the Investors and that each of the Investors
has full legal power and right to enter into this Agreement, a valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except as enforcement
thereof may be limited by the effect of bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, or similar laws affecting the enforcement of creditors’ rights generally,
and subject to principles of equity and public policy.

ARTICLE III

Registration Rights

          Section 3.01 Demand Registrations.

               (a) Requests for Registration. At any time after the date of this Agreement, subject to the
conditions set forth herein, each Investor shall be entitled to make, on its own behalf or on
behalf of any of its Affiliates, a written request of the Company (a “Demand”) for
registration under the Securities Act of all or any portion of the Registrable Securities owned by
such Investor (or such Investor’s Affiliates) (a “Demand Registration”). The Investor
making such Demand (the “Demanding Investor”) shall give written notice (a “Demand
Notice”) to the Company and to the other Investor specifying: (i) the Demanding

4

 

Investor’s intent to exercise a Demand; (ii) the aggregate number of Registrable Securities
requested to be registered, provided that such Registrable Securities must have an aggregate Fair
Market Value of at least $10,000,000; and (iii) the intended method of distribution in connection
with such Demand Registration to the extent then known. Within ten (10) business days of receipt
of a Demand Notice, the other Investor, should it wish to participate in the Demand Registration,
shall give written notice (a “Demand Participation Notice”) to the Company and the
Demanding Investor specifying the aggregate number of Registrable Securities that such Investor, on
its own behalf or on behalf of any of its Affiliates, wishes to be included in the Demand
Registration. Participation by such Investor in such Demand Registration pursuant to a Demand
Participation Notice shall not be counted as a Demand of such Investor. Subject to Section
3.01(f), the Company shall include in the Demand Registration all Registrable Securities requested
to be included in such Demand Registration by the Demanding Investor and the other Investor, as set
forth in the Demand Participation Notice.

               (b) Number of Demands. Each Investor shall be entitled to four (4) Demand Registrations.

               (c) Satisfaction of Obligations. Subject to the provisions of Section 3.03, a registration
shall not be treated as a permitted Demand for a Demand Registration until (i) the applicable
registration statement under the Securities Act has been filed with the Commission with respect to
such Demand Registration (which shall include any registration statement that is not withdrawn by
holders of Registrable Securities in the circumstances contemplated by Section 3.03); and (ii) such
registration statement shall have been maintained continuously effective for a period of at least
one hundred eighty (180) days or, in the case of a registration statement registering securities
pursuant to Rule 415 under the Securities Act, until all securities registered under such
registration statement are sold.

               (d) Availability of Short Form Registrations. The Company shall use its commercially
reasonable efforts to comply with the requirements for use of short form registration for the sale
of Registrable Securities under the Securities Act.

               (e) Restrictions on Demand Registrations. The Company shall not be obligated (i) in the case
of a Demand Registration, to maintain the effectiveness of a registration statement under the
Securities Act for a period of at least 180 days or, in the case of a registration statement
registering securities pursuant to Rule 415 under the Securities Act, until all securities
registered under such Demand Registration are sold; or (ii) to effect any Demand Registration
requested by an Investor within one hundred eighty (180) days of the effective date of (A) a
registration in which such Investor, on its own behalf or on behalf of any of its Affiliates,
exercised “piggyback” rights pursuant to Section 3.02 hereof (provided that, with respect to such a
registration in which such piggyback rights were exercised, such Investor was permitted to include
in such registration at least twenty-five percent (25%) of the Registrable Securities that such
Investor and its Affiliates sought to include therein) or (B) any other Demand Registration. In
addition, the Company shall be entitled to postpone (upon written notice to each Investor) for up
to ninety (90) days the filing or the effectiveness of a registration statement in respect of a
Demand (but no more than once in any period of twelve (12) consecutive months) if the Board
determines in good faith and in its reasonable judgment that effecting the Demand Registration in
respect of such Demand would have a material adverse effect on any proposal or plan by the

5

 

Company to engage in any debt or equity offering, material acquisition, or disposition of
assets (other than in the ordinary course of business) or any merger, consolidation, tender offer,
or other similar transaction or otherwise would be materially detrimental to the Company. In the
event of a postponement by the Company of the filing or effectiveness of a registration statement
in respect of a Demand, the Demanding Investor shall have the right to withdraw such Demand in
accordance with Section 3.03 hereof.

               (f) Participation in Demand Registrations. Except with the prior written consent of the
Demanding Investor, the Company may not include any securities to be sold for the Company’s account
or for the account of other Persons that are not holders of Registrable Securities, other than the
other Investor and its Affiliates, in a Demand Registration. If, in connection with a Demand
Registration, any managing underwriter advises the Company and the Demanding Investor that, in its
opinion, the inclusion of all the Registrable Securities and, if authorized pursuant to this
Article III, other securities of the Company, in each case, sought to be registered in connection
with such Demand Registration would adversely affect the marketability of the Registrable
Securities sought to be sold pursuant thereto, then the Company shall include in the registration
statement applicable to such Demand Registration only such securities as the Company, the Demanding
Investor, and the other Investor are advised by such underwriter can be sold without such an effect
(the “Maximum Demand Number”), as follows and in the following order of priority:

          (i) first, the number of Registrable Securities sought to be registered
by the Demanding Investor, on its own behalf or on behalf of any of its Affiliates,
pursuant to such Demand and the number of Registrable Securities, if any, sought to
be registered by the other Investor, on its own behalf or on behalf of any of its
Affiliates, pursuant to a Demand Participation Notice; provided, however, that, in
the event that the aggregate number of Registrable Securities to be sold pursuant to
this clause (i) exceeds the Maximum Demand Number, then the number of Registrable
Securities to be registered by each of the Demanding Investor and the other Investor
shall be reduced pro rata in proportion to the number of Registrable Securities
sought to be registered by each such Investor such that the total number of
Registrable Securities to be registered equals the Maximum Demand Number; and

          (ii) second, and only if the number of Registrable Securities to be
included under clause (i) above is less than the Maximum Demand Number, the number
of securities sought to be included by the Company, which in the aggregate, when
added to the number of securities to be included pursuant to clause (i) above,
equals the Maximum Demand Number; and

          (iii) third, and only if the number of Registrable Securities to be
included under clauses (i) and (ii) above is less than the Maximum Demand Number,
the number of securities sought to be sold for the account of other Persons that the
Company is obligated to register pursuant to written contractual arrangements with
such Persons, pro rata in proportion to the number of securities sought to be sold
by such Persons, which in the aggregate, when added

6

 

to the number of securities to be included pursuant to clauses (i) and (ii)
above, equals the Maximum Demand Number.

               (g) Selection of Underwriters. If the Demanding Investor requests that such Demand
Registration be an underwritten offering, then the Demanding Investor shall select a nationally
recognized underwriter or underwriters to manage and administer such offering, such underwriter or
underwriters, as the case may be, to be subject to the approval of the Company and the other
Investor (to the extent such other Investor has delivered a Demand Participation Notice), which
approval shall not be unreasonably withheld or delayed.

               (h) Other Registrations. If the Company has received a Demand and if the applicable
registration statement in respect of such Demand has not been withdrawn or abandoned, the Company
shall not file or cause to be effected any other registration of any of its equity securities or
securities convertible or exchangeable into or exercisable for its equity securities under the
Securities Act (other than a registration relating to the Company’s employee benefit plans,
exchange offers by the Company, or a merger or acquisition of a business or assets by the Company,
including, without limitation, a registration on Form S-4 or Form S-8 or any successor form),
whether on its own behalf or at the request of any holder or holders of such securities, until a
period of at least ninety (90) days has elapsed from the effective date of any Demand Registration,
unless a shorter period of time is approved by the Demanding Investor. Notwithstanding the
foregoing, the Company shall be entitled to postpone any such Demand Registration and may file or
cause to be effected such other registration in accordance with the terms of Section 3.01(e)
hereof.

          Section 3.02 Piggyback Registrations.

               (a) Right to Piggyback. Whenever the Company proposes to register any shares of its Common
Stock or Common Stock held by any stockholders of the Company under the Securities Act (other than
a registration under Regulation A or relating to the Company’s employee benefit plans, exchange
offers by the Company, or a merger or acquisition of a business or assets by the Company,
including, without limitation, a registration on Form S-4 or Form S-8 or any successor form) (a
“Piggyback Registration”), the Company shall give each of the Investors prompt written
notice thereof (but not less than ten (10) business days prior to the filing by the Company with
the Commission of any registration statement with respect thereto). Such notice (a “Piggyback
Notice”) shall specify the number of securities proposed to be registered, the proposed date of
filing of such registration statement with the Commission, the proposed means of distribution, the
proposed managing underwriter or underwriters (if any and if known), and a good faith estimate by
the Company of the proposed minimum offering price of such securities. Upon the written request of
an Investor, on its own behalf or on behalf of any of its Affiliates, given to the Secretary of the
Company within ten (10) business days of the receipt by such Investor of the Piggyback Notice
requesting that the Company include in such registration Registrable Securities owned by such
Investor or its Affiliates in an amount equal to or greater than the Requisite Amount (which
written request shall specify the number of Registrable Securities intended to be disposed of by
such Investor and its Affiliates and the intended method of distribution thereof), the Company
shall include in such registration all Registrable Securities with respect to which the Company has
received such written requests for inclusion, in accordance with the terms hereof.

7

 

               (b) Priority on Piggyback Registrations. If, in connection with a Piggyback Registration, any
managing underwriter (or, if such Piggyback Registration is not an underwritten offering, a
nationally recognized independent underwriter selected by the Company) advises the Company and the
holders of the Registrable Securities to be included in such Piggyback Registration, that, in its
opinion, the inclusion of all the securities sought to be included in such Piggyback Registration
by the Company, by any Persons other than the Investors who have sought to have shares registered
thereunder pursuant to rights to demand (other than pursuant to so-called “piggyback” or other
incidental or participation registration rights) such registration (such demand rights, being
“Other Demand Rights” and such other Persons, being “Other Demanding Sellers”), by
any holders of securities (including the Investors) seeking to sell such securities in such
Piggyback Registration (“Piggyback Sellers”), in each case, if any would materially
adversely affect the marketability of the securities sought to be sold pursuant thereto, then the
Company shall include in the registration statement applicable to such Piggyback Registration only
such securities as the Company, the Other Demanding Sellers, and the Piggyback Sellers are so
advised by such underwriter can be sold without such an effect (the “Maximum Piggyback
Number”), as follows and in the following order of priority:

          (i) if the Piggyback Registration is an offering on behalf of the Company and
not a Demanding Investor pursuant to Section 3.01 hereof or any Person exercising
Other Demand Rights (whether or not other Persons seek to include securities therein
pursuant to so-called “piggyback” or other incidental or participatory registration
rights) (a “Primary Offering”), then (A) first, such number of
securities to be sold by the Company as the Company, in its reasonable judgment and
acting in good faith and in accordance with sound financial practice, shall have
determined; and (B) second, if the number of securities to be included under
clause (A) above is less than the Maximum Piggyback Number, pro rata in proportion
to the securities sought to be registered by all the Piggyback Sellers which in the
aggregate, when added to the number of securities to be registered under clause (A)
above, equals the Maximum Piggyback Number; and

          (ii) if the Piggyback Registration is an offering other than pursuant to a
Primary Offering or a Demand Registration, then (A) first, such number of
securities sought to be registered by each Other Demanding Seller, pro rata in
proportion to the number of securities sought to be registered by all such Other
Demanding Sellers; and (B) second, if the number of securities to be
included under clause (A) above is less than the Maximum Piggyback Number, the
number of securities sought to be registered by each Piggyback Seller, pro rata in
proportion to the securities sought to be registered by all the Piggyback Sellers,
which in the aggregate, when added to the number of securities to be registered
under clause (A) above, equals the Maximum Piggyback Number; and (C) third,
if the number of securities to be included under clauses (A) and (B) above is less
than the Maximum Piggyback Number, the number of securities to be sold by the
Company for its own account, which in the aggregate, when added to the number of
securities to be registered under clauses (A) and (B) above, equals the Maximum
Piggyback Number.

8

 

               (c) Withdrawal by the Company. If, at any time after giving written notice of its intention
to register any of its securities as set forth in this Section 3.02 and prior to the time the
registration statement filed in connection with such registration is declared effective, the
Company shall determine not to go forward with a Primary Offering, the Company may, at its
election, give written notice of such determination to each Investor and thereupon shall be
relieved of its obligation to register any Registrable Securities in connection with such
particular withdrawn or abandoned registration (but not from its obligation to pay the Registration
Expenses in connection therewith as provided herein).

          Section 3.03 Withdrawal Rights. Any Investor that has, on its own behalf or on behalf of any
of its Affiliates, notified or directed the Company to include any Registrable Securities in a
registration statement under the Securities Act shall have the right to withdraw any such notice or
direction with respect to any or all of the Registrable Securities designated for registration
thereby by giving written notice to such effect to the Company prior to the effective date of such
registration statement. In the event of any such withdrawal, the Company shall not include such
Registrable Securities in the applicable registration, and such Registrable Securities shall
continue to be Registrable Securities hereunder. No such withdrawal shall affect the obligations
of the Company with respect to the Registrable Securities not so withdrawn; provided that in the
case of a Demand Registration, if such withdrawal shall reduce the number of Registrable Securities
sought to be included in such registration below $10,000,000 of aggregate Fair Market Value as of
such date, then the Company shall as promptly as practicable give each holder of Registrable
Securities sought to be registered notice to such effect, referring to this Agreement and
summarizing this Section 3.03, and within five (5) business days of the effectiveness of such
notice either the Company or the holders of a majority of the Registrable Securities sought to be
registered may, by written notices made to each holder of Registrable Securities sought to be
registered and the Company, elect that such registration statement not be filed or, if theretofore
filed, be withdrawn. During such period of five (5) business days, the Company shall not file such
registration statement if not theretofore filed, or, if such registration statement has been
theretofore filed, the Company shall not seek, and shall use its best efforts to prevent, the
effectiveness thereof. Any Demand Registration withdrawn in accordance with an election by the
Demanding Investor subsequent to the effectiveness of the applicable Demand Registration Statement
shall be counted as a Demand Registration unless such Demanding Investor reimburses the Company for
its reasonable out-of-pocket expenses related to the preparation and filing of such registration
statement (in which event such registration statement shall not be counted as a Demand Registration
hereunder).

          Section 3.04 Holdback Agreements. Each Investor agrees not to effect any public sale or
distribution (including sales pursuant to Rule 144 (or any successor provision) promulgated under
the Securities Act) of equity securities of the Company, or any securities convertible into or
exchangeable or exercisable for such securities, during the twenty (20) day period prior to the
date on which the Company intends to commence a Public Offering (provided the Investors are
notified in writing of such commencement date) through the ninety (90) day period immediately
following the effective date of any such Public Offering (except as part of such registration), or,
if later, the ninety (90) day period immediately following the execution date of any underwriting agreement
with respect thereto.

          Section 3.05 Registration Procedures.

9

 

               (a) Whenever the Investors have, on their own behalf or on the behalf of any of their
respective Affiliates, requested that any Registrable Securities be registered pursuant to this
Agreement, the Company (subject to its right to withdraw such registration as contemplated by
Section 3.02(c)) shall use commercially reasonable efforts to effect the registration and the sale
of such Registrable Securities in accordance with the intended method of disposition thereof, and,
in connection therewith, the Company shall:

          (i) use commercially reasonable efforts to (A) register the Registrable
Securities on Form S-3 or another available short form registration statement, to
the extent permitted under the Securities Act and the rules and regulations
thereunder, (B) cause the registration statement to remain effective for a
continuous period of not less than 180 days (or, if earlier, until all of the
Registrable Securities included in such registration statement have been sold
thereunder), subject to Section 3.05(c), and (C) obtain the withdrawal of any order
suspending the registration or qualification (or the effectiveness thereof) or
suspending or preventing the use of any related prospectus in any jurisdiction with
respect thereto;

          (ii) promptly notify each seller of Registrable Securities of each of (A) the
filing and effectiveness of the registration statement and prospectus and any
amendment or supplements thereto, (B) the receipt of any comments from the
Commission or any state securities law authorities or any other governmental
authorities with respect to any such registration statement or prospectus or any
amendments or supplements thereto, and (C) any oral or written stop order with
respect to such registration, any suspension of the registration or qualification of
the sale of such Registrable Securities in any jurisdiction, or any initiation or
threatening of any proceedings with respect to any of the foregoing;

          (iii) furnish to each seller of Registrable Securities, the underwriters, and
the sales or placement agent, if any, and counsel for each of the foregoing, a
conformed copy of such registration statement and each amendment and supplement
thereto (in each case, including all exhibits thereto and documents incorporated by
reference therein) and such additional number of copies of such registration
statement, each amendment, and supplement thereto (in such case without such
exhibits and documents), the prospectus (including each preliminary prospectus)
included in such registration statement, and prospectus supplements and all exhibits
thereto and documents incorporated by reference therein, and such other documents as
such seller, underwriter, agent, or counsel may reasonably request in order to
facilitate the disposition of the Registrable Securities owned by such seller;

          (iv) use commercially reasonable efforts to register or qualify such
Registrable Securities under such securities or “blue sky” laws of such
jurisdictions as the holders of Registrable Securities reasonably request and do any
and all other acts and things that may be reasonably necessary or advisable to
enable the holders of Registrable Securities to consummate the disposition in such
jurisdictions of the Registrable Securities owned by such holders and keep such

10

 

registration or qualification in effect for so long as the registration statement
remains effective under the Securities Act (provided that the Company shall not be
required to (x) qualify generally to do business in any jurisdiction in which it
would not otherwise be required to qualify but for this paragraph, (y) subject
itself to taxation in any such jurisdiction in which it would not otherwise be
subject to taxation but for this paragraph, or (z) consent to the general service of
process in any jurisdiction in which it would not otherwise be subject to general
service of process but for this paragraph);

          (v) notify each seller of such Registrable Securities, at any time when a
prospectus relating thereto is required to be delivered under the Securities Act and
the rules and regulations thereunder, upon the discovery that, or of the happening
of any event as a result of which, the registration statement covering such
Registrable Securities, as then in effect, contains an untrue statement of a
material fact or omits to state any material fact required to be stated therein or
any fact necessary to make the statements therein not misleading, and promptly
prepare and furnish to each such seller a supplement or amendment to the prospectus
contained in such registration statement so that such Registration Statement shall
not, and such prospectus as thereafter delivered to the purchasers of such
Registrable Securities shall not, contain an untrue statement of a material fact or
omit to state any material fact required to be stated therein or any fact necessary
to make the statements therein not misleading;

          (vi) use commercially reasonable efforts to cause all such Registrable
Securities to be listed on any national securities exchange or established
over-the-counter market on which or through which similar securities of the Company
are then listed or traded and, if not so listed or traded, to use commercially
reasonable efforts to cause such Registrable Securities to be listed on The Nasdaq
Stock Market or to be listed on an automated quotation system and to secure
designation of all such Registrable Securities covered by such registration
statement as an “NMS Security” within the meaning of Regulation NMS under the
Exchange Act;

          (vii) provide and cause to be maintained a transfer agent and registrar for all
such Registrable Securities covered by such registration statement not later than
the effective date of such registration statement;

          (viii) make available for inspection by any seller of Registrable Securities
and any attorney, accountant, or other agent retained by any such seller or
underwriter all financial and other records, pertinent corporate documents, and
properties of the Company, and cause the Company’s officers, directors, employees,
attorneys, and independent accountants to supply all information reasonably
requested by any such sellers, attorneys, accountants, or agents in connection with
such registration statement. Information that the Company determines, in good
faith, to be confidential shall not be disclosed by such Persons unless (x) the
disclosure of such information is necessary to avoid or correct a misstatement or
omission in such registration statement, or (y) the

11

 

release of such information is
ordered pursuant to a subpoena or other order from a court of competent
jurisdiction. Each seller of Registrable Securities agrees, on its own behalf and
on behalf of all its accountants, attorneys, and agents, that the information
obtained by it as a result of such inspections shall be deemed confidential and
shall not be used by it as the basis for any market transactions in the securities
of the Company unless and until such is made generally available to the public.
Each seller of Registrable Securities further agrees, on its own behalf and on
behalf of all its accountants, attorneys, and agents, that it will, upon learning
that disclosure of such information is sought in a court of competent jurisdiction,
give notice to the Company and allow the Company, at the Company’s expense, to
undertake appropriate action to prevent disclosure of the information deemed
confidential;

          (ix) use commercially reasonable efforts to comply with all applicable laws
related to such registration statement and offering and sale of securities and all
applicable rules and regulations of governmental authorities in connection therewith
(including, without limitation, the Securities Act and the Exchange Act) and make
generally available to its security holders as soon as practicable (but in any event
not later than fifteen (15) months after the effectiveness of such registration
statement) an earnings statement of the Company and its subsidiaries complying with
Section 11(a) of the Securities Act;

          (x) permit any Investor, which Investor, in its sole and exclusive judgment,
might be deemed to be an underwriter or controlling Person of the Company, to
participate in the preparation of such registration statement and to require the
insertion therein of material, furnished to the Company in writing, that in the
reasonable judgment of such holder and such holder’s counsel should be included; and

          (xi) use commercially reasonable efforts to furnish to each seller of
Registrable Securities a signed counterpart of (x) an opinion of counsel for the
Company and (y) a “comfort” letter signed by the independent public accountants who
have certified the Company’s financial statements included or incorporated by
reference in such registration statement, covering such matters with respect to such
registration statement and, in the case of the accountants’ comfort letter, with
respect to events subsequent to the date of such financial statements, as are
customarily covered in opinions of issuer’s counsel and in accountants’ comfort
letters delivered to the underwriters in underwritten public offerings of securities
for the account of, or on behalf of, an issuer of common stock, such opinion and
comfort letters to be dated the date of such opinions and comfort letters are
customarily dated in such transactions, and covering in the case of such legal
opinion, such other legal matters and, in the case of such comfort letter, such
other financial matters, as the holders of a majority of the Registrable Securities
being sold may reasonably request.

          (b) Underwriting. Without limiting any of the foregoing, in the event that the offering of
Registrable Securities is to be made by or through an underwriter, the

12

 

Company shall enter into an
underwriting agreement with a managing underwriter or underwriters containing representations,
warranties, indemnities, and agreements customarily included (but not inconsistent with the
agreements contained herein) by an issuer of common stock in underwriting agreements with respect
to offerings of common stock for the account of, or
on behalf of, such an issuer. In connection with the sale of Registrable Securities
hereunder, any seller of such Registrable Securities may, at its option, require that any and all
representations and warranties by, and indemnities and agreements of, the Company to or for the
benefit of such underwriter or underwriters (or which would be made to or for the benefit of such
an underwriter or underwriters if such sale of Registrable Securities were pursuant to a customary
underwritten offering) be made to and for the benefit of such seller and that any or all of the
conditions precedent to the obligations of such underwriter or underwriters (or which would be so
for the benefit of such underwriter or underwriters under a customary underwriting agreement) be
conditions precedent to the obligations of such seller in connection with the disposition of its
securities pursuant to the terms hereof. In connection with any offering of Registrable Securities
registered pursuant to this Agreement, the Company shall (x) furnish to the underwriter, if any
(or, if no underwriter, the sellers of such Registrable Securities), unlegended certificates
representing ownership of the Registrable Securities being sold, in such denominations as requested
and (y) instruct any transfer agent and registrar of the Registrable Securities to release any stop
transfer order with respect thereto.

          (c) Return of Prospectuses. Each seller of Registrable Securities hereunder agrees that upon
receipt of any notice from the Company of the happening of any event of the kind described in
Section 3.05(a)(v), such seller shall forthwith discontinue such seller’s disposition of
Registrable Securities pursuant to the applicable registration statement and prospectus relating
thereto until such seller’s receipt of the copies of the supplemented or amended prospectus
contemplated by Section 3.05(a)(v) and, if so directed by the Company, deliver to the Company all
copies, other than permanent file copies, then in such seller’s possession of the prospectus
current at the time of receipt of such notice relating to such Registrable Securities. In the
event the Company shall give such notice, the one hundred and eighty (180) day period during which
such registration statement must remain effective pursuant to Section 3.05(a)(i) of this Agreement
(or such shorter period as permitted by Section 3.05(a)(i)) shall be extended by the number of days
during the period from the date of giving of a notice regarding the happening of an event of the
kind described in Section 3.05(a)(v) to the date when all such sellers shall receive such a
supplemented or amended prospectus and such prospectus shall have been filed with the Commission.

     Section 3.06 Registration Expenses. All expenses incident to the Company’s performance of, or
compliance with, its obligations under this Agreement, including, without limitation, all
registration and filing fees, all fees and expenses of compliance with securities and “blue sky”
laws (including, without limitation, the fees and expenses of counsel for underwriters or placement
or sales agents in connection therewith), all printing and copying expenses, all messenger and
delivery expenses, all fees and expenses of underwriters and sales and placement agents in
connection therewith (excluding discounts and commissions of such underwriters or placement
agents), all fees and expenses of the Company’s independent certified public accountants and
counsel (including, without limitation, with respect to “comfort” letters and opinions)
(collectively, the “Registration Expenses”) shall be borne by the Company. Notwithstanding
the foregoing, all underwriting discounts and commissions allocable to each

13

 

Investor selling, or
effecting the sale of, Registrable Securities on its own behalf or on behalf of any of its
Affiliates shall be borne by such Investor. The Company shall not be responsible for the fees and
expenses of any additional counsel, or any of the accountants, agents, or experts retained by the
Investors in connection with the sale of Registrable Securities. The Company will pay its internal
expenses (including, without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties, the expense of any annual audit, and the expense of any
liability insurance) and the expenses and fees for listing the securities to be registered on each
securities exchange and included in each established over-the-counter market on which similar
securities issued by the Company are then listed or traded or for listing on any other exchange or
automated quotation system.

     Section 3.07 Indemnification.

          (a) By the Company. The Company agrees to indemnify, to the fullest extent permitted by law,
each holder of Registrable Securities being sold, its directors, officers, employees, members,
managers, partners, agents, and each other Person, if any, who controls (within the meaning of the
Securities Act and the rules and regulations thereunder) such holder against all losses, claims,
damages, liabilities, and expenses (including legal fees and expenses and all costs incident to
investigation or preparation with respect to such losses, claims, damages, liabilities, and
expenses and to reimburse such indemnified Person for such costs as incurred) (collectively, the
“Losses”) caused by, resulting from, or relating to any untrue or alleged untrue statement
of material fact contained in any registration statement, prospectus, or preliminary prospectus or
any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required
to be stated therein or a fact necessary to make the statements therein not misleading, except
insofar as the same are caused by or contained in any information furnished to the Company by or on
behalf of such holder in writing expressly for use therein or by such holder’s failure to deliver a
copy of the registration statement or prospectus or any amendments or supplements thereto after the
Company has furnished such holder with a sufficient number of copies of the same and notified such
holder of such obligation. In connection with an underwritten offering and without limiting any of
the Company’s other obligations under this Agreement, the Company shall indemnify such
underwriters, their officers, directors, employees, and agents and each Person who controls (within
the meaning of the Securities Act and the rules and regulations thereunder) such underwriters or
such an other indemnified Person to the same extent as provided above with respect to the
indemnification of the holders of Registrable Securities being sold.

          (b) By the Investors. In connection with any registration statement in which a holder of
Registrable Securities is participating, each such holder will, if requested, furnish to the
Company in writing information regarding such holder’s ownership of Registrable Securities and, to
the extent permitted by law, shall indemnify the Company, its directors, and each Person who
controls (within the meaning of the Securities Act and the rules and regulations thereunder) the
Company against all Losses caused by, resulting from, or relating to any untrue or alleged untrue
statement of material fact contained in the registration statement, prospectus, or preliminary
prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a
material fact required to be stated therein or necessary to make the statements therein not
misleading, but only to the extent that such untrue statement or omission is caused by and
contained in such information so furnished to the Company in writing by or on

14

 

behalf of such
holder; provided, however, that each holder’s obligation to indemnify the Company hereunder shall
be apportioned between each holder based upon the net amount received by each holder from the sale
of Registrable Securities, as compared to the total net amount received by all of the holders of
Registrable Securities sold pursuant to such registration statement, no such holder being liable to
the Company in excess of such apportionment.

          (c) Notice. Any Person entitled to indemnification hereunder shall give prompt written notice
to the indemnifying party of any claim with respect to which its seeks indemnification; provided,
however, that the failure to give such notice shall not release the indemnifying party from its
obligation, except to the extent that the indemnifying party has been materially prejudiced by such
failure to provide such notice.

          (d) Defense of Actions. In any case in which any such action is brought against any
indemnified party and it notifies an indemnifying party of the commencement thereof, the
indemnifying party will be entitled to participate therein and, to the extent that it may wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party, and, after notice from the indemnifying
party to such indemnified party of its election so to assume the defense thereof, the indemnifying
party will not (so long as it shall continue to have the right to defend, contest, litigate, and
settle the matter in question in accordance with this paragraph) be liable to such indemnified
party hereunder for any legal or other expense subsequently incurred by such indemnified party in
connection with the defense thereof other than reasonable costs of investigation, supervision, and
monitoring (unless such indemnified party reasonably objects to such assumption on the grounds that
there may be defenses available to it that are different from or in addition to the defenses
available to such indemnifying party, in which event the indemnified party shall be reimbursed by
the indemnifying party for the expenses incurred in connection with retaining separate legal
counsel). An indemnifying party shall not be liable for any settlement of an action or claim
effected without its consent. The indemnifying party shall lose its right to defend, contest,
litigate, and settle a matter if it shall fail diligently to contest such matter (except to the
extent settled in accordance with the next following sentence). No matter shall be settled by an
indemnifying party without the consent of the indemnified party (which consent shall not be
unreasonably withheld).

          (e) Survival. The indemnification provided for under this Agreement shall remain in full
force and effect regardless of any investigation made by or on behalf of the indemnified Person and
will survive the transfer of the Registrable Securities and the termination of this Agreement.

          (f) Contribution. If recovery is not available under the foregoing indemnification provisions
for any reason or reasons other than as specified therein, any Person who would otherwise be
entitled to indemnification by the terms thereof shall nevertheless be entitled to contribution
with respect to any Losses with
respect to which such Person would be entitled to such indemnification but for such reason or
reasons. In determining the amount of contribution to which the respective Persons are entitled,
there shall be considered the Persons’ relative knowledge and access to information concerning the
matter with respect to which the claim was asserted, the opportunity to correct and prevent any
statement or omission, and other equitable considerations appropriate under the circumstances. It
is hereby agreed that it would

15

 

not necessarily be
equitable if the amount of such contribution were determined by pro rata or per capita allocation.
No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any Person who was not found guilty of such
fraudulent misrepresentation. Notwithstanding the foregoing, no Investor (and no Affiliate of such
Investor) shall be required to make a contribution in excess of the net amount received by such
Investor (or its Affiliate) from the sale of Registrable Securities.

ARTICLE IV

Miscellaneous

          Section 4.01 Inconsistent Agreements. Without the prior written consent of each Investor, the
Company shall not enter into any registration rights agreement that conflicts, or is inconsistent,
with the provisions of Article III hereof.

          Section 4.02 Specific Performance. Each of the Investors and the Company acknowledge and
agree that, in the event of any breach of this Agreement, the non-breaching party or parties would
be irreparably harmed and could not be made whole by monetary damages. The Investors and the
Company hereby agree that, in addition to any other remedy to which the Investors may be entitled
at law or in equity, each Investor shall be entitled to compel specific performance of this
Agreement in any action instituted in any court of the United States or any state thereof having
subject matter jurisdiction for such action.

          Section 4.03 Headings. The headings in this Agreement are for convenience of reference only
and shall not control or affect the meaning or construction of any provisions hereof.

          Section 4.04 Entire Agreement. This Agreement constitutes the entire agreement and
understanding of the parties hereto in respect of the subject matter contained herein, and there
are no restrictions, promises, representations, warranties, covenants, conditions, or undertakings
with respect to the subject matter hereof, other than those expressly set forth or referred to
herein. This Agreement amends and supersedes all prior agreements and understandings between the
parties hereto with
respect to the subject matter hereof, including that certain Second Amended and Restated
Stockholders Agreement, dated as of June 2, 2005, among the Company, Building Products, LLC, Floyd
F. Sherman, Charles L. Horn, Kevin P. O’Meara, and Donald F. McAleenan.

          Section 4.05 Notices. All notices and other communications hereunder shall be in writing and
shall be delivered personally, by next-day courier, by electronic or facsimile transmission, or
telecopied with confirmation of receipt to the parties at the addresses specified below (or at such
other address for a party as shall be specified by like notice; provided that notices of change of
address shall be effective only upon receipt thereof). Any such notice shall be effective upon
receipt, if personally delivered, delivered by electronic or facsimile transmission, or telecopied,
or one day after delivery to a courier for next-day delivery.

          If to the Company, to:

16

 

Builders FirstSource, Inc.

2001 Bryan Street, Suite 1600

Dallas, Texas 75201

Facsimile: (214) 880-3599

Attention: Donald F. McAleenan, Esq.

with a copy to:

Alston & Bird LLP

One Atlantic Center

1201 West Peachtree Street

Atlanta, Georgia 30309-3424

Facsimile: (404) 253-8376

Attention: William Scott Ortwein

If to JLL Fund V, to:

JLL Partners Fund V, L.P.

c/o JLL Partners, Inc.

450 Lexington Avenue, 31st Floor

New York, New York 10017

Facsimile: (212) 286-8626

Attention: Brett N. Milgrim

                  Daniel Agroskin

with a copy to:

Skadden, Arps, Slate, Meagher & Flom LLP

One Rodney Square

Wilmington, Delaware 19801

Facsimile: (302) 651-3001

Attention: Robert B. Pincus, Esq.

                   Allison L. Land, Esq.

If to Warburg Pincus, to:

Warburg Pincus Private Equity IX, L.P.

c/o Warburg Pincus LLC

450 Lexington Avenue, 32nd Floor

New York, New York 10017

Facsimile: (212) 878-9100

Attention: David Barr

                  Kevin Kruse

with a copy to:

Willkie Farr & Gallagher LLP

17

 

787 Seventh Avenue

New York, New York 10019-6099

Facsimile: (212) 728-8111

Attention: Steven J. Gartner, Esq.

                  Mark Cognetti, Esq.

          Section 4.06 Applicable Law. The substantive laws of the State of Delaware shall govern the
interpretation, validity, and performance of the terms of this Agreement, regardless of the law
that might be applied under applicable principles of conflicts of laws.

          Section 4.07 Severability. The invalidity, illegality, or unenforceability of one or more of
the provisions of this Agreement in any jurisdiction shall not affect the validity, legality, or
enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality,
or enforceability of this Agreement, including any such provision, in any other jurisdiction, it
being intended that all rights and obligations of the parties hereunder shall be enforceable to the
fullest extent permitted by law.

          Section 4.08 Successors; Assigns. The provisions of this Agreement shall be binding upon the
parties hereto and their respective heirs, successors, and permitted assigns, including, without
limitation and without the need for an express assignment or assumption, any successor in interest
to an Investor, whether by a sale of all or substantially all of its assets, merger, consolidation,
or otherwise. Neither this Agreement nor the rights or obligations of any party hereunder may be
assigned, except as otherwise provided in this Agreement. Any such attempted assignment in
contravention of this Agreement shall be void and of no effect.

          Section 4.09 Amendments. This Agreement may not be amended, modified, or supplemented unless
such modification is in writing and signed by the Company and each Investor.

          Section 4.10 Waiver. Any waiver (express or implied) of any default or breach of this
Agreement shall not constitute a waiver of any other or subsequent default or breach.

          Section 4.11 Counterparts. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original but all of which shall constitute one and the same Agreement.

          Section 4.12 Term. Unless earlier terminated, this Agreement shall terminate upon the seventh
anniversary of the date of this Agreement; provided, however, that to the extent that any Demand
Registration or Piggyback Registration has commenced at such time, this Agreement shall remain in
effect until the termination or expiration of such Demand Registration or Piggyback Registration,
as the case may be, and the Investors’ obligations pursuant to Section 3.04 hereof shall continue
until ninety (90) days following the effectiveness of the registration statement related thereto.
Notwithstanding the foregoing, each Investor may at any time provide written notice to the Company
of its irrevocable election to withdraw from all of its rights and obligations under this
Agreement. In such event, from and after the date of such notice, such Investor shall no longer be
bound by any obligations, or be entitled to any

18

 

benefits, under this Agreement (other than those
that have accrued prior to such date), and from and after such time, securities held directly or
indirectly by such Investor shall no longer be deemed to be Registrable Securities hereunder.

[SIGNATURE PAGE FOLLOWS]

19

 

          IN WITNESS WHEREOF, the undersigned hereby agree to be bound by the terms and provisions of
this Registration Rights Agreement as of the date first above written.

	 	 	 	 	 
	 	BUILDERS FIRSTSOURCE, INC.

 	 
	 	By:  	/s/ Donald F. McAleenan
 	 
	 	 	Name:  	Donald F. McAleenan 	 
	 	 	Title:  	Senior Vice President, General Counsel, and Secretary 	 
	 
	 	JLL PARTNERS FUND V, L.P.

 	 
	 	By:  	JLL Associates V, L.P., its general partner
 	 
	 	 	 
	 	By:  	                                      JLL Associates G.P. V, L.L.C., its general partner
 	 
	 
	 	By:  	                                      /s/ Paul S. Levy
 	 
	 	 	Name:  	Paul S. Levy 	 
	 	 	Title:  	Managing Member 	 
	 
	 	WARBURG PINCUS PRIVATE EQUITY IX, L.P.

 	 
	 	By:  	Warburg Pincus IX LLC, General Partner
 	 
	 	 	 
	 	By:  	                                      Warburg Pincus Partners, LLC, Sole Member
 	 
	 	 	 
	 	By:  	                                      Warburg Pincus & Co., Managing Member
 	 
	 	 	 
	 	By:  	                                      /s/ Kevin  Kruse
 	 
	 	 	Name:  	Kevin Kruse 	 
	 	 	Title:  	Partner 	 

20Exhibit 4.1

Exhibit 4.1

EXECUTION VERSION

REGISTRATION RIGHTS AGREEMENT

by and among

CROSSTEX ENERGY, L.P.

and

THE PURCHASER PARTY HERETO

 

 

Table of Contents

	 	 	 	 	 
	ARTICLE I DEFINITIONS
	 	 	1	 
	 
	 	 	 	 
	Section 1.1 Definitions
	 	 	1	 
	Section 1.2 Registrable Securities
	 	 	3	 
	 
	 	 	 	 
	ARTICLE II REGISTRATION RIGHTS
	 	 	4	 
	 
	 	 	 	 
	Section 2.1 Shelf Registration
	 	 	4	 
	Section 2.2 Piggyback Registration
	 	 	5	 
	Section 2.3 Underwritten Offering
	 	 	7	 
	Section 2.4 Sale Procedures
	 	 	7	 
	Section 2.5 Cooperation by Holders
	 	 	11	 
	Section 2.6 Restrictions on Public Sale by Holders of Registrable Securities
	 	 	11	 
	Section 2.7 Expenses
	 	 	12	 
	Section 2.8 Indemnification
	 	 	12	 
	Section 2.9 Rule 144 Reporting
	 	 	14	 
	Section 2.10 Transfer or Assignment of Registration Rights
	 	 	15	 
	Section 2.11 Limitation on Subsequent Registration Rights
	 	 	15	 
	Section 2.12 Aggregation of Registrable Securities
	 	 	15	 
	Section 2.13 Common Unit Notices
	 	 	15	 
	Section 2.14 Remarketing
	 	 	15	 
	 
	 	 	 	 
	ARTICLE III MISCELLANEOUS
	 	 	15	 
	 
	 	 	 	 
	Section 3.1 Communications
	 	 	15	 
	Section 3.2 Successors and Assigns
	 	 	17	 
	Section 3.3 Assignment of Rights
	 	 	17	 
	Section 3.4 Recapitalization (Exchanges, etc. Affecting the Common Units)
	 	 	17	 
	Section 3.5 Specific Performance
	 	 	17	 
	Section 3.6 Counterparts
	 	 	17	 
	Section 3.7 Headings
	 	 	17	 
	Section 3.8 Governing Law, Submission to Jurisdiction
	 	 	17	 
	Section 3.9 Waiver of Jury Trial
	 	 	18	 
	Section 3.10 Severability of Provisions
	 	 	18	 
	Section 3.11 Entire Agreement
	 	 	18	 
	Section 3.12 Amendment
	 	 	18	 
	Section 3.13 No Presumption
	 	 	18	 
	Section 3.14 Obligations Limited to Parties to Agreement
	 	 	18	 
	Section 3.15 Interpretation
	 	 	19	 

 

i

 

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of
January 19, 2010 by and between CROSSTEX ENERGY, L.P., a Delaware limited partnership
(“Crosstex”), and the party set forth on Schedule A hereto (the
“Purchaser”).

WHEREAS, this Agreement is made in connection with the Closing of the issuance and sale of the
Purchased Units pursuant to the Series A Convertible Preferred Unit Purchase Agreement, dated as of
January 6, 2010, by and between Crosstex and the Purchaser (the “Purchase Agreement”);

WHEREAS, Crosstex has agreed to provide the registration and other rights set forth in this
Agreement for the benefit of the Purchaser pursuant to the Purchase Agreement; and

WHEREAS, it is a condition to the obligations of the Purchaser and Crosstex under the Purchase
Agreement that this Agreement be executed and delivered;

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and
for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by
each party hereto, the parties hereby agree as follows:

ARTICLE I

DEFINITIONS

Section 1.1 Definitions.
The terms set forth below are used herein as so defined:

“Affiliate” means, with respect to a specified Person, any other Person, directly or
indirectly controlling, controlled by or under direct or indirect common control with such
specified Person. For purposes of this definition, “control” (including, with correlative meanings,
“controlling,” “controlled by,” and “under common control with”) means the power to direct or cause
the direction of the management and policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise.

“Business Day” means any day other than a Saturday, Sunday, any federal legal holiday
or day on which banking institutions in the State of New York or State of Texas are authorized or
required by law or other governmental action to close.

“Closing” shall have the meaning set forth in the Purchase Agreement.

“Closing Date” shall have the meaning set forth in the Purchase Agreement.

“Commission” means the United States Securities and Exchange Commission.

“Common Units” shall have the meaning set forth in the Purchase Agreement.

“Crosstex” has the meaning specified therefor in the introductory paragraph of this
Agreement.

 

1

 

“Effective Date” means the date of effectiveness of the Shelf Registration Statement.

“Effectiveness Period” has the meaning specified therefor in Section 2.1(a) of
this Agreement.

“Eighth Anniversary Date” has the meaning specified therefor in Section 2.1(a)
of this Agreement.

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to
time, and the rules and regulations of the Commission promulgated thereunder.

“Filing Date” has the meaning specified therefore in Section 2.1(a) of this
Agreement.

“General Partner” shall have the meaning set forth in the Purchase Agreement.

“Holder” means the record holder of any Registrable Securities.

“Included Registrable Securities” has the meaning specified therefor in Section
2.2(a) of this Agreement.

“Law” shall have the meaning set forth in the Purchase Agreement.

“Liquidated Damages” has the meaning specified therefor in Section 2.1(b).

“Losses” has the meaning specified therefor in Section 2.8(a) of this
Agreement.

“Managing Underwriter” means, with respect to any Underwritten Offering, the book
running lead manager of such Underwritten Offering.

“NASDAQ” means the NASDAQ Global Select Market.

“Non-Disclosure Agreements” shall have the meaning set forth in the Purchase
Agreement.

“Other Holder” has the meaning specified in Section 2.2(b).

“Other Registrable Securities” means Registrable Securities as defined in that certain
Registration Rights Agreement, dated as of March 23, 2007, among Crosstex and the purchasers named
therein.

“Partnership Agreement” shall have the meaning set forth in the Purchase Agreement.

“Person” means any individual, corporation, company, voluntary association,
partnership, joint venture, trust, limited liability company, unincorporated organization,
government or any agency, instrumentality or political subdivision thereof, or any other form of
entity.

 

2

 

“Piggyback Registration” has the meaning specified therefor in Section 2.2(a)
of this Agreement.

“Purchase Agreement” has the meaning specified therefor in the Recitals of this
Agreement.

“Purchase Price” shall have the meaning set forth in the Purchase Agreement.

“Purchased Units” shall have the meaning set forth in the Purchase Agreement.

“Purchaser” has the meaning set forth in the introductory paragraph of this Agreement.

“Registration” means any registration pursuant to this Agreement, including pursuant
to the Shelf Registration Statement or a Piggyback Registration.

“Registrable Securities” means the Common Units to be issued upon conversion of the
Purchased Units, all of which are subject to the rights provided herein until such rights terminate
pursuant to the provisions of this Agreement.

“Registration Expenses” has the meaning specified therefor in Section 2.7(a)
of this Agreement.

“Securities Act” means the Securities Act of 1933, as amended from time to time, and
the rules and regulations of the Commission promulgated thereunder.

“Selling Expenses” has the meaning specified therefor in Section 2.7(a) of
this Agreement.

“Selling Holder” means a Holder who is selling Registrable Securities pursuant to a
registration statement.

“Selling Holder Underwriter Registration Statement” has the meaning specified therefor
in Section 2.4(p) of this Agreement.

“Shelf Registration Statement” means a registration statement under the Securities Act
to permit the public resale of the Registrable Securities from time to time as permitted by Rule
415 of the Securities Act (or any similar provision then in force under the Securities Act).

“Underwritten Offering” means an offering (including an offering pursuant to a Shelf
Registration Statement) in which Common Units are sold to an underwriter on a firm commitment basis
for reoffering to the public or an offering that is a “bought deal” with one or more investment
banks.

Section 1.2 Registrable Securities. Any Registrable Security will cease to be a Registrable Security at the earliest of the
following: (a) when a registration statement covering such Registrable Security has been declared
effective by the Commission and such Registrable Security has been sold or disposed of pursuant to
such effective registration statement; (b) when

 

3

 

such Registrable Security has been disposed of
pursuant to any Section of Rule 144 (or any similar provision then in force) under the Securities
Act; (c) when such Registrable Security is held by Crosstex or one of its subsidiaries; (d) when
such Registrable Security has been sold in a private transaction in which the transferor’s rights
under this Agreement are not assigned to the transferee of such securities; and (e) two years from
the Effective Date.

ARTICLE II

REGISTRATION RIGHTS

Section 2.1 Shelf Registration.

(a) Shelf Registration. As soon as practicable following receipt of written notice
from the holders of a majority of the Registrable Securities requesting the filing of the Shelf
Registration Statement, Crosstex shall use its reasonable best efforts to prepare and file a Shelf
Registration Statement under the Securities Act covering the Registrable Securities; provided that
the right of such holders to request such filing shall expire on the eighth anniversary of the
Closing Date (the “Eighth Anniversary Date”). Crosstex shall use its reasonable best efforts to
cause the Shelf Registration Statement to become effective no later than 180 days after the date of
filing of such Shelf Registration Statement (the “Filing Date”). A Shelf Registration
Statement filed pursuant to this Section 2.l(a) shall be on such appropriate registration
form of the Commission as shall be selected by Crosstex; provided, however, that if
a prospectus supplement will be used in connection with the marketing of an Underwritten Offering
from the Shelf Registration Statement and the Managing Underwriter at any time shall notify
Crosstex in writing that, in the sole judgment of such Managing Underwriter, inclusion of detailed
information to be used in such prospectus supplement is of material importance to the success of
the Underwritten Offering of such Registrable Securities, Crosstex shall use its commercially
reasonable efforts to include such information in the prospectus. Crosstex will use its
commercially reasonable efforts to cause the Shelf Registration Statement filed pursuant to this
Section 2.l(a) to be continuously effective under the Securities Act until the earliest of
(i) all Registrable Securities covered by the Shelf Registration Statement have been distributed in
the manner set forth and as contemplated in the Shelf Registration Statement, (ii) there are no
longer any Registrable Securities outstanding and (iii) two years from the Effective Date (the
“Effectiveness Period”). The Shelf Registration Statement when declared effective
(including the documents incorporated therein by reference) will comply as to form in all material
respects with all applicable requirements of the Securities Act and the Exchange Act and will not
contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading (and, in the case of any
prospectus contained in such Shelf Registration Statement, in the light of the circumstances under
which a statement is made). As soon as practicable following the date that the Shelf Registration
Statement becomes effective, but in any event within five (5) Business Days of such date,
Crosstex shall provide the Holders with written notice of the effectiveness of the Shelf
Registration Statement.

(b) Failure to Become Effective. If the Shelf Registration Statement required by
Section 2.1(a) does not become or is not declared effective within 180 days after the
Filing Date, then the Purchaser shall be entitled to a payment (with respect to each of the
Purchaser’s Purchased Units), as liquidated damages and not as a penalty, of 0.25% of the Purchase
Price per 30-day period for the first sixty (60) days following the 180th day after the
Filing Date, with such payment amount increasing by an additional 0.25% of the Purchase Price per

 

4

 

30-day period for each subsequent 60 days, up to a maximum of 1.00% of the Purchase Price per
30-day period (the “Liquidated Damages”), until such time as the Shelf Registration
Statement is declared effective or there are no longer any Registrable Securities outstanding. The
Liquidated Damages shall accrue on a daily basis and be paid to the Purchaser in cash within ten
(10) Business Days of the end of such 30-day period. Any Liquidated Damages shall be paid to the
Purchaser in cash or immediately available funds. For the avoidance of doubt, nothing in this
Section 2.1(b) shall relieve Crosstex from its obligations under Section 2.1(a).

(c) Delay Rights. Notwithstanding anything to the contrary contained herein, Crosstex
may, upon written notice to any Selling Holder whose Registrable Securities are included in the
Shelf Registration Statement, suspend such Selling Holder’s use of any prospectus which is a part
of the Shelf Registration Statement (in which event the Selling Holder shall discontinue sales of
the Registrable Securities pursuant to the Shelf Registration Statement) if (i) Crosstex is
pursuing an acquisition, merger, reorganization, disposition or other similar transaction and
Crosstex determines in good faith that Crosstex’s ability to pursue or consummate such a
transaction would be materially and adversely affected by any required disclosure of such
transaction in the Shelf Registration Statement or (ii) Crosstex has experienced some other
material non-public event the disclosure of which at such time, in the good faith judgment of
Crosstex, would materially and adversely affect Crosstex; provided, however, that
in no event shall the Selling Holders be suspended from selling Registrable Securities pursuant to
the Shelf Registration Statement for a period that exceeds an aggregate of sixty (60) days in any
one hundred-eighty (180) day period or ninety (90) days in any 365 day period. Upon disclosure of
such information or the termination of the condition described above, Crosstex shall provide prompt
notice to the Selling Holders whose Registrable Securities are included in the Shelf Registration
Statement, and shall promptly terminate any suspension of sales it has put into effect and shall
take such other actions necessary or appropriate to permit registered sales of Registrable
Securities as contemplated in this Agreement.

Section 2.2 Piggyback Registration.

(a) Participation. If at any time Crosstex proposes to file (i) during the
Effectiveness Period a prospectus supplement to an effective shelf registration statement, other
than the Shelf Registration Statement contemplated by Section 2.1, or (ii) prior to (A) the
expiration of the Effectiveness Period or (B) if the Effectiveness Period has not begun by the
Eighth Anniversary Date, the Eighth Anniversary Date, a registration statement, other than a
shelf registration statement, in either case (i) or (ii), for the sale of Common Units in an
Underwritten Offering for its own account and/or the account of another Person, then, as soon as
practicable following the engagement of counsel to Crosstex to prepare the documents to be used in
connection with an Underwritten Offering, Crosstex shall give notice of such proposed Underwritten
Offering to the Holders as soon as practicable but not less than three Business Days following such
engagement of counsel by Crosstex, and such notice shall offer the Holders the opportunity to
include in such Underwritten Offering such number of Registrable Securities (the “Included
Registrable Securities”) as each such Holder may request in writing (a “Piggyback
Registration”); provided, however, that Crosstex shall not be required to offer
such opportunity to Holders if the Holders do not offer a minimum of $5,000,000 of Registrable

 

5

 

Securities and Other Registrable Securities, in the aggregate, (determined by multiplying the
number of Registrable Securities and Other Registrable Securities owned by the average of the
closing price on NASDAQ for Common Units for the ten (10) trading days preceding the date of such
notice). The notice required to be provided in this Section 2.2(a) to Holders shall be
provided on a Business Day pursuant to Section 3.1 hereof and confirmation of receipt of
such notice shall be requested in the notice. Holder shall then have two (2) Business Days to
request inclusion of Registrable Securities in the Underwritten Offering. If no request for
inclusion from a Holder is received within the specified time, such Holder shall have no further
right to participate in such Piggyback Registration. If, at any time after giving written notice of
its intention to undertake an Underwritten Offering and prior to the closing of such Underwritten
Offering, Crosstex shall determine for any reason not to undertake or to delay such Underwritten
Offering, Crosstex may, at its election, give written notice of such determination to the Selling
Holders and, (x) in the case of a determination not to undertake such Underwritten Offering, shall
be relieved of its obligation to sell any Included Registrable Securities in connection with such
terminated Underwritten Offering, and (y) in the case of a determination to delay such Underwritten
Offering, shall be permitted to delay offering any Included Registrable Securities for the same
period as the delay in the Underwritten Offering. Any Selling Holder shall have the right to
withdraw such Selling Holder’s request for inclusion of such Selling Holder’s Registrable
Securities in such Underwritten Offering by giving written notice to Crosstex of such withdrawal up
to and including the time of pricing of such offering. No Holders shall be entitled to participate
in any such Underwritten Offering under this Section 2.2(a) unless such Holder (together
with any Affiliates that are Selling Holders) participating therein holds at least fifteen million
dollars ($15,000,000) of Registrable Securities and Other Registrable Securities, in the aggregate,
(determined by multiplying the number of Registrable Securities and Other Registrable Securities
owned by the average of the closing price for Common Units for the ten (10) trading days preceding
the date of such notice).

(b) Priority of Piggyback Registration. If the Managing Underwriter or Underwriters
of any proposed Underwritten Offering of Common Units included in a Piggyback Registration advises
Crosstex that the total amount of Common Units which the Selling Holders and any other Persons
intend to include in such offering exceeds the number which can be sold in such offering without
being likely to have an adverse effect on the price, timing or distribution of the Common Units
offered or the market for the Common Units, then the Common Units to be included in such
Underwritten Offering shall include the number of Common Units that such Managing Underwriter or
Underwriters advises Crosstex can be sold without having such adverse effect, with such number to
be allocated pro rata among the Selling Holders, the holders of Other Registrable Securities and
any other Persons who have been or are granted registration
rights on or after the date of this Agreement (together with the holders of Other Registrable
Securities, the “Other Holders”) who have requested participation in the Piggyback
Registration (based, for each such Selling Holder or Other Holder, on the percentage derived by
dividing (A) the number of Common Units proposed to be sold by such Selling Holder or such Other
Holder in such offering; by (B) the aggregate number of Common Units proposed to be sold by all
Selling Holders and all Other Holders in the Piggyback Registration.

 

6

 

Section 2.3 Underwritten Offering.

(a) S-3 Registration. In the event that a Selling Holder (together with any Affiliates
that are Selling Holders) elects to dispose of Registrable Securities under the Shelf Registration
Statement pursuant to an Underwritten Offering of at least fifteen million dollars ($15,000,000) of
Registrable Securities and Other Registrable Securities, Crosstex shall, at the request of such
Selling Holder, enter into an underwriting agreement in customary form with the Managing
Underwriter or Underwriters, which shall include, among other provisions, indemnities to the effect
and to the extent provided in Section 2.8, and shall take all such other reasonable actions
as are requested by the Managing Underwriter in order to expedite or facilitate the disposition of
the Registrable Securities.

(b) General Procedures. In connection with any Underwritten Offering (i) under
Section 2.2 of this Agreement, Crosstex shall be entitled to select the Managing
Underwriter or Underwriters, and (ii) under Section 2.3 of this Agreement, the Selling
Holders shall be entitled to select the Managing Underwriter or Underwriters. In connection with an
Underwritten Offering contemplated by this Agreement in which a Selling Holder participates, each
Selling Holder and Crosstex shall be obligated to enter into an underwriting agreement with the
Managing Underwriter or Underwriters which contains such representations, covenants, indemnities
and other rights and obligations as are customary in underwriting agreements for firm commitment
offerings of equity securities. No Selling Holder may participate in such Underwritten Offering
unless such Selling Holder agrees to sell its Registrable Securities on the basis provided in such
underwriting agreement and completes and executes all questionnaires, powers of attorney,
indemnities and other documents reasonably required under the terms of such underwriting agreement.
Each Selling Holder may, at its option, require that any or all of the representations and
warranties by, and the other agreements on the part of, Crosstex to and for the benefit of such
underwriters also be made to and for such Selling Holder’s benefit and that any or all of the
conditions precedent to the obligations of such underwriters under such underwriting agreement also
be conditions precedent to its obligations. No Selling Holder shall be required to make any
representations or warranties to or agreements with Crosstex or the underwriters other than
representations, warranties or agreements regarding such Selling Holder and its ownership of the
securities being registered on its behalf and its intended method of distribution and any other
representation required by law. If any Selling Holder disapproves of the terms of an underwriting,
such Selling Holder may elect to withdraw therefrom by notice to Crosstex and the Managing
Underwriter; provided, however, that such withdrawal must be made prior to the
pricing of such Underwritten Offering to be effective. No such withdrawal or abandonment shall
affect Crosstex’s obligation to pay Registration Expenses. Upon the receipt by Crosstex of a
written request from the Holders of at least fifteen million dollars ($15,000,000)
of Common Units that are participating in any Underwritten Offering contemplated by this
Agreement, Crosstex’s management shall be required to participate in a roadshow or similar
marketing effort in connection with any Underwritten Offering.

Section 2.4 Sale Procedures. In connection with its obligations under this Article II, Crosstex will, as
expeditiously as possible:

(a) prepare and file with the Commission such amendments and supplements to the Shelf
Registration Statement and the prospectus used in connection therewith as may be

 

7

 

necessary to keep
the Shelf Registration Statement effective for the Effectiveness Period and as may be necessary to
comply with the provisions of the Securities Act with respect to the disposition of all securities
covered by the Shelf Registration Statement;

(b) if a prospectus supplement will be used in connection with the marketing of an
Underwritten Offering from the Shelf Registration Statement and the Managing Underwriter at any
time shall notify Crosstex in writing that, in the sole judgment of such Managing Underwriter, the
inclusion of detailed information to be used in such prospectus supplement is of material
importance to the success of the Underwritten Offering of such Registrable Securities, Crosstex
shall use its commercially reasonable efforts to include such information in the prospectus
supplement;

(c) furnish to each Selling Holder (i) as far in advance as reasonably practicable before
filing the Shelf Registration Statement or any other registration statement contemplated by this
Agreement or any supplement or amendment thereto, upon request, copies of reasonably complete
drafts of all such documents proposed to be filed (including exhibits and each document
incorporated by reference therein to the extent then required by the rules and regulations of the
Commission), and provide each such Selling Holder the opportunity to object to any information
pertaining to such Selling Holder and its plan of distribution that is contained therein and make
the corrections reasonably requested by such Selling Holder with respect to such information prior
to filing the Shelf Registration Statement or such other registration statement and the prospectus
included therein or any supplement or amendment thereto, and (ii) such number of copies of the
Shelf Registration Statement or such other registration statement and the prospectus included
therein and any supplements and amendments thereto as such Persons may reasonably request in order
to facilitate the public sale or other disposition of the Registrable Securities covered by such
Shelf Registration Statement or other registration statement;

(d) if applicable, use its commercially reasonable efforts to register or qualify the
Registrable Securities covered by the Shelf Registration Statement or any other registration
statement contemplated by this Agreement under the securities or blue sky laws of such
jurisdictions as the Selling Holders or, in the case of an Underwritten Offering, the Managing
Underwriter, shall reasonably request, provided that Crosstex will not be required to qualify
generally to transact business in any jurisdiction where it is not then required to so qualify or
to take any action which would subject it to general service of process in any such jurisdiction
where it is not then so subject;

(e) promptly notify each Selling Holder and each underwriter, at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of (i) the filing of the
Shelf Registration Statement or any other registration statement contemplated by this Agreement or
any prospectus included therein or any amendment or supplement thereto, and, with respect to such
Shelf Registration Statement or any other registration statement or any post-effective amendment
thereto, when the same has become effective; and (ii) the receipt of any written comments from the
Commission with respect to any filing referred to in clause (i) and any written request by the
Commission for amendments or supplements to the Shelf Registration Statement or any other
registration statement or any prospectus or prospectus supplement thereto;

 

8

 

(f) immediately notify each Selling Holder and each underwriter, at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of (i) the happening of any
event as a result of which the prospectus contained in the Shelf Registration Statement or any
other registration statement contemplated by this Agreement or any supplemental amendment thereto,
includes an untrue statement of a material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein not misleading in the light of the
circumstances then existing; (ii) the issuance or threat of issuance by the Commission of any stop
order suspending the effectiveness of the Shelf Registration Statement or any other registration
statement contemplated by this Agreement, or the initiation of any proceedings for that purpose; or
(iii) the receipt by Crosstex of any notification with respect to the suspension of the
qualification of any Registrable Securities for sale under the applicable securities or blue sky
laws of any jurisdiction. Following the provision of such notice, Crosstex agrees to as promptly as
practicable amend or supplement the prospectus or prospectus supplement or take other appropriate
action so that the prospectus or prospectus supplement does not include an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading in the light of the circumstances then existing and to take
such other action as is necessary to remove a stop order, suspension, threat thereof or proceedings
related thereto;

(g) upon request and subject to appropriate confidentiality obligations, furnish to each
Selling Holder copies of any and all transmittal letters or other correspondence with the
Commission or any other governmental agency or self-regulatory body or other body having
jurisdiction (including any domestic or foreign securities exchange) relating to such offering of
Registrable Securities;

(h) in the case of an Underwritten Offering, furnish upon request, (i) an opinion of counsel
for Crosstex, dated the effective date of the applicable registration statement or the date of any
amendment or supplement thereto, preliminary or prospectus supplement, and a letter of like kind
dated the date of the closing under the underwriting agreement, and (ii) a “cold comfort” letter,
dated the pricing date of such Underwritten Offering and a letter of like kind dated the date of
the closing under the underwriting agreement, in each case, signed by the independent public
accountants who have certified Crosstex’s financial statements included or incorporated by
reference into the applicable registration statement, and each of the opinion and the “cold
comfort” letter shall be in customary form and covering substantially the same matters with respect
to such registration statement (and the prospectus included therein and any supplement thereto) and
as are customarily covered in opinions of issuer’s counsel and in
accountants’ letters delivered to the underwriters in underwritten offerings of securities,
such other matters as such underwriters may reasonably request;

(i) otherwise use its commercially reasonable efforts to comply with all applicable rules and
regulations of the Commission, and make available to its security holders, as soon as reasonably
practicable, an earnings statement covering the period of at least 12 months, but not more than 18
months, beginning with the first full calendar month after the effective date of such registration
statement, which earnings statement shall satisfy the provisions of Section l1(a) of the Securities
Act and Rule 158 promulgated thereunder;

 

9

 

(j) make available to the appropriate representatives of the Managing Underwriter and Selling
Holders access to such information and Crosstex personnel as is reasonable and customary to enable
such parties to establish a due diligence defense under the Securities Act; provided that Crosstex
need not disclose any non-public information to any such representative unless and until such
representative has entered into a confidentiality agreement with Crosstex;

(k) cause all such Registrable Securities registered pursuant to this Agreement to be listed
on each securities exchange or nationally recognized quotation system on which similar securities
issued by Crosstex are then listed;

(l) use its commercially reasonable efforts to cause the Registrable Securities to be
registered with or approved by such other governmental agencies or authorities as may be necessary
by virtue of the business and operations of Crosstex to enable the Selling Holders to consummate
the disposition of such Registrable Securities;

(m) provide a transfer agent and registrar for all Registrable Securities covered by such
registration statement not later than the effective date of such registration statement;

(n) enter into customary agreements and take such other actions as are reasonably requested by
the Selling Holders or the underwriters, if any, in order to expedite or facilitate the disposition
of such Registrable Securities;

(o) if reasonably requested by a Selling Holder, (i) incorporate in a prospectus supplement or
post-effective amendment such information as such Selling Holder reasonably requests to be included
therein relating to the sale and distribution of Registrable Securities, including information with
respect to the number of Registrable Securities being offered or sold, the purchase price being
paid therefor and any other terms of the offering of the Registrable Securities to be sold in such
offering; and (ii) make all required filings of such prospectus supplement or post-effective
amendment after being notified of the matters to be incorporated in such prospectus supplement or
post-effective amendment; and

(p) (i) cooperate with such Selling Holder if any Selling Holder could reasonably be deemed to
be an “underwriter,” as defined in Section 2(a)(11) of the Securities Act, in connection with the
registration statement in respect of any registration of the Registrable Securities of the
Purchaser pursuant to this Agreement, and any amendment or supplement thereof (any such
registration statement or amendment or supplement a “Selling Holder Underwriter Registration
Statement”), in allowing such Selling Holder to conduct customary
“underwriter’s due diligence” with respect to Crosstex and satisfy its obligations in respect
thereof, (ii) furnish to such Selling Holder upon such Selling Holder’s request, on the date of the
effectiveness of any Selling Holder Underwriter Registration Statement and thereafter from time to
time on such dates as such Selling Holder may reasonably request, (A) a “cold comfort” letter,
dated such date, from Crosstex’s independent certified public accountants in form and substance as
is customarily given by independent certified public accountants to underwriters in an underwritten
public offering, addressed to the Purchaser, (B) an opinion, dated as of such date, of counsel
representing Crosstex for purposes of such Selling Holder Underwriter Registration Statement, in
form, scope and substance as is customarily given in an underwritten public

 

10

 

offering, including a
standard “10b-5” opinion for such offering, addressed to such Selling Holder and (C) a standard
officer’s certificate from the chief executive officer or chief financial officer, or other
officers serving such functions, of the General Partner addressed to the Selling Holder;
provided, however, that with respect to any placement agent, Crosstex’s obligations
with respect to this Section 2.4(p) shall be limited to one time, with an additional
bring-down request within 30 days of the date of such documents, and (iii) permit legal counsel to
such Selling Holder to review and comment upon any such Selling Holder Underwriter Registration
Statement at least five (5) Business Days prior to its filing with the Commission and all
amendments and supplements to any such Selling Holder Underwriter Registration Statement within a
reasonable number of days prior to their filing with the Commission and not file any Selling Holder
Underwriter Registration Statement or amendment or supplement thereto in a form to which the
Purchaser’s legal counsel reasonably objects in writing.

Each Selling Holder, upon receipt of notice from Crosstex of the happening of any event of the
kind described in subsection (f) of this Section 2.4, shall forthwith discontinue
disposition of the Registrable Securities until such Selling Holder’s receipt of the copies of the
supplemented or amended prospectus contemplated by subsection (f) of this Section 2.4 or
until it is advised in writing by Crosstex that the use of the prospectus may be resumed, and has
received copies of any additional or supplemental filings incorporated by reference in the
prospectus, and, if so directed by Crosstex, such Selling Holder will, or will request the Managing
Underwriter or underwriters, if any, to deliver to Crosstex (at Crosstex’s expense) all copies in
their possession or control, other than permanent file copies then in such Selling Holder’s
possession, of the prospectus and any prospectus supplement covering such Registrable Securities
current at the time of receipt of such notice.

Section 2.5 Cooperation by Holders. Crosstex shall have no obligation to include Registrable Securities of a Holder in the
Shelf Registration Statement or in an Underwritten Offering under Article II of this
Agreement if such Selling Holder has failed to timely furnish such information which, in the
opinion of counsel to Crosstex, is reasonably required in order for the registration statement or
prospectus supplement, as applicable, to comply with the Securities Act.

Section 2.6 Restrictions on Public Sale by Holders of Registrable Securities. For a period of one year following the Effective Date, each Holder of Registrable
Securities who is included in the Shelf Registration Statement agrees not to effect any public sale
or distribution of the Registrable Securities during the 30 calendar day period beginning on the
date of a prospectus supplement filed with the Commission with respect to the pricing of an
Underwritten Offering, or other prospectus (including any free writing prospectus) containing the
terms of the pricing of such Underwritten Offering, provided that the duration of the foregoing
restrictions shall be no longer than the duration of the shortest restriction generally imposed by
the underwriters on the officers or directors or any other unitholder of Crosstex on whom a
restriction is imposed and provided further that such Selling Holder (together with any Affiliates
that are Selling Holders) owns at least fifteen million dollars ($15,000,000) of Registrable
Securities, and Other Registration Securities, in the aggregate (determined by multiplying the
number of Registrable Securities and Other Registrable Securities owned by the average of the
closing price for Common Units for the ten (10) trading days preceding the date of such filing).

 

11

 

Section 2.7 Expenses.

(a) Certain Definitions. “Registration Expenses” means all expenses incident
to Crosstex’s performance under or compliance with this Agreement to effect the registration of
Registrable Securities in a Shelf Registration pursuant to Section 2.1, a Piggyback
Registration pursuant to Section 2.2, or an Underwritten Offering pursuant to Section
2.3, and the disposition of such securities, including, without limitation, all registration,
filing, securities exchange listing and NASDAQ fees, all registration, filing, qualification and
other fees and expenses of complying with securities or blue sky laws, fees of the Financial
Industry Regulatory Authority, including, transfer taxes and fees of transfer agents and
registrars, all word processing, duplicating and printing expenses, the fees and disbursements of
counsel and independent public accountants for Crosstex, including the expenses of any special
audits or “cold comfort” letters required by or incident to such performance and compliance. Except
as otherwise provided in Section 2.8 hereof, Crosstex shall not be responsible for legal
fees incurred by Holders in connection with the exercise of such Holders’ rights hereunder. In
addition, Crosstex shall not be responsible for any “Selling Expenses,” which means all
underwriting fees, discounts and selling commissions and transfer taxes allocable to the sale of
the Registrable Securities.

(b) Expenses. Crosstex will pay all reasonable Registration Expenses in connection
with a Shelf Registration, a Piggyback Registration or Underwritten Offering, whether or not any
sale is made pursuant to such Shelf Registration, Piggyback Registration or Underwritten Offering.
Each Selling Holder shall pay all Selling Expenses in connection with any sale of its Registrable
Securities hereunder.

Section 2.8 Indemnification.

(a) By Crosstex. In the event of a registration of any Registrable Securities under
the Securities Act pursuant to this Agreement, Crosstex will indemnify and hold harmless each
Selling Holder thereunder, its directors, officers, employees, agents and managers, and each
underwriter, pursuant to the applicable underwriting agreement with such underwriter, of
Registrable Securities thereunder and each Person, if any, who controls such Selling Holder or
underwriter within the meaning of the Securities Act and the Exchange Act, and its directors,
officers, employees, agents and managers, against any losses, claims, damages, expenses or
liabilities (including reasonable attorneys’ fees and expenses) (collectively, “Losses”),
joint or several, to which such Selling Holder or underwriter or controlling Person may become
subject under the Securities Act, the Exchange Act or otherwise, insofar as such Losses (or actions
or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of any material fact (in the case of any
prospectus, in light of the circumstances under which such statement is made) contained in the
Shelf Registration Statement or any other registration statement contemplated by this Agreement,
any preliminary prospectus or final prospectus contained therein, or any free writing prospectus
related thereto, or any amendment or supplement thereof, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein (in the case of a prospectus, in light of the
circumstances under which they were made) not misleading, and will reimburse each such Selling
Holder, its directors and officers, each such underwriter and each such controlling Person for any
legal or other expenses reasonably incurred by them in connection with investigating or

 

12

 

defending
any such Loss or actions or proceedings; provided, however, that Crosstex will not
be liable in any such case if and to the extent that any such Loss arises out of or is based upon
an untrue statement or alleged untrue statement or omission or alleged omission so made in strict
conformity with information furnished by such Selling Holder, such underwriter or such controlling
Person in writing specifically for use in the Shelf Registration Statement or such other
registration statement, or prospectus supplement, as applicable. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of such Selling Holder
or any such director, officer, employee, agent, manager or controlling Person, and shall survive
the transfer of such securities by such Selling Holder.

(b) By Each Selling Holder. Each Selling Holder agrees severally and not jointly to
indemnify and hold harmless Crosstex, its directors, officers, employees and agents and each
Person, if any, who controls Crosstex within the meaning of the Securities Act or of the Exchange
Act to the same extent as the foregoing indemnity from Crosstex to the Selling Holders, but only
with respect to information regarding such Selling Holder furnished in writing by or on behalf of
such Selling Holder expressly for inclusion in the Shelf Registration Statement or prospectus
supplement relating to the Registrable Securities, or any amendment or supplement thereto;
provided, however, that the liability of each Selling Holder shall not be greater
in amount than the dollar amount of the proceeds (net of any Selling Expenses) received by such
Selling Holder from the sale of the Registrable Securities giving rise to such indemnification.

(c) Notice. Promptly after receipt by an indemnified party hereunder of notice of the
commencement of any action, such indemnified party shall, if a claim in respect thereof is to be
made against the indemnifying party hereunder, notify the indemnifying party in writing thereof,
but the omission so to notify the indemnifying party shall not relieve it from any liability which
it may have to any indemnified party other than under this Section 2.8(c) except to the
extent that the indemnifying party is materially prejudiced by such failure. In any action brought
against any indemnified party, it shall notify the indemnifying party of the commencement thereof.
The indemnifying party shall be entitled to participate in and, to the extent it shall wish, to
assume and undertake the defense thereof with counsel reasonably satisfactory to such indemnified
party and, after notice from the indemnifying party to such indemnified party of its election so to
assume and undertake the defense thereof, the
indemnifying party shall not be liable to such indemnified party under this Section
2.8 for any legal expenses subsequently incurred by such indemnified party in connection with
the defense thereof other than reasonable costs of investigation and of liaison with counsel so
selected; provided, however, that, (i) if the indemnifying party has failed to
assume the defense and employ counsel or (ii) if the defendants in any such action include both the
indemnified party and the indemnifying party and counsel to the indemnified party shall have
concluded that there may be reasonable defenses available to the indemnified party that are
different from or additional to those available to the indemnifying party, or if the interests of
the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying
party, then the indemnified party shall have the right to select a separate counsel and to assume
such legal defense and otherwise to participate in the defense of such action, with the reasonable
expenses and fees of such separate counsel and other reasonable expenses related to such
participation to be reimbursed by the indemnifying party as incurred. Notwithstanding any other
provision of this Agreement, the indemnifying party shall not settle any indemnified claim without
the consent of the indemnified party, unless the settlement thereof imposes no liability or
obligation on,

 

13

 

includes a complete release from liability of, and does not contain any admission of
wrong doing by, the indemnified party.

(d) Contribution. If the indemnification provided for in this Section 2.8 is
held by a court or government agency of competent jurisdiction to be unavailable to Crosstex or any
Selling Holder or is insufficient to hold them harmless in respect of any Losses, then each such
indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount
paid or payable by such indemnified party as a result of such Losses in such proportion as is
appropriate to reflect the relative fault of Crosstex on the one hand and of such Selling Holder on
the other in connection with the statements or omissions which resulted in such Losses, as well as
any other relevant equitable considerations; provided, however, that in no event
shall such Selling Holder be required to contribute an aggregate amount in excess of the dollar
amount of proceeds (net of Selling Expenses) received by such Selling Holder from the sale of
Registrable Securities giving rise to such indemnification. The relative fault of Crosstex on the
one hand and each Selling Holder on the other shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact has been made by, or relates to, information supplied by
such party, and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The parties hereto agree that it would not be just
and equitable if contributions pursuant to this paragraph were to be determined by pro rata
allocation or by any other method of allocation which does not take account of the equitable
considerations referred to in the first sentence of this paragraph. The amount paid by an
indemnified party as a result of the Losses referred to in the first sentence of this paragraph
shall be deemed to include any legal and other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any Loss which is the subject of this
paragraph. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any Person who is not guilty of such
fraudulent misrepresentation.

(e) Other Indemnification. The provisions of this Section 2.8 shall be in
addition to any other rights to indemnification or contribution which an indemnified party may have
pursuant to law, equity, contract or otherwise.

Section 2.9 Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations of the
Commission that may permit the sale of the Registrable Securities to the public without
registration, Crosstex agrees to use its commercially reasonable efforts to:

(a) Make and keep public information regarding Crosstex available, as those terms are
understood and defined in Rule 144 of the Securities Act, at all times from and after the date
hereof;

(b) File with the Commission in a timely manner all reports and other documents required of
Crosstex under the Securities Act and the Exchange Act at all times from and after the date hereof;
and

 

14

 

(c) So long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon
request a copy of the most recent annual or quarterly report of Crosstex, and such other reports
and documents so filed as such Holder may reasonably request in availing itself of any rule or
regulation of the Commission allowing such Holder to sell any such securities without registration.

Section 2.10 Transfer or Assignment of Registration Rights. The rights to cause Crosstex to register Registrable Securities granted to the Purchaser by
Crosstex under this Article II may be transferred or assigned by the Purchaser to one or
more transferee(s) or assignee(s) of such Registrable Securities, who (a) are Affiliates of the
Purchaser, or (b) hold, collectively with its or their Affiliates, after giving effect to such
transfer or assignment, at least fifteen million dollars ($15,000,000) of Registrable Securities
and Other Registrable Securities. Crosstex shall be given written notice prior to any said transfer
or assignment, stating the name and address of each such transferee and identifying the securities
with respect to which such registration rights are being transferred or assigned, and each such
transferee shall assume in writing responsibility for its obligations of the Purchaser under this
Agreement.

Section 2.11 Limitation on Subsequent Registration Rights. From and after the date hereof, Crosstex shall not, without the prior written consent of
the Holders of a majority of the outstanding Registrable Securities, enter into any agreement with
any current or future holder of any securities of Crosstex that would allow such current or future
holder to require Crosstex to include securities in any registration statement filed by Crosstex on
a basis that is superior in any way to the piggyback rights granted to the Purchaser hereunder.

Section 2.12 Aggregation of Registrable Securities. All Registrable Securities held or acquired by Persons who are Affiliates of one another
shall be aggregated together for the purpose of determining the availability of any rights under
this Agreement.

Section 2.13 Common Unit Notices. The Partnership shall distribute to the holders of Purchased Units copies of all notices,
materials, annual and quarterly reports, proxy statements, information statements and any other
documents distributed generally to the holders of Common Units, at such times and by such method as
such documents are distributed to such holders of Common Units.

Section 2.14 Remarketing. If any holder of Purchased Units approaches the Partnership with a desire to sell more than
1,500,000 Purchased Units in a private sale pursuant to an exemption from the registration
requirements of the Securities Act, or Registrable Securities having equivalent economic value, the
Partnership shall cooperate reasonably with such holder to provide information reasonably requested
by potential purchasers, to make the Partnership’s management reasonably available by telephone and
to confirm that the Partnership has made all requisite filings required by the Exchange Act.

ARTICLE III

MISCELLANEOUS

Section 3.1 Communications. All notices and demands provided for hereunder shall be in writing and shall be given by
registered or certified mail, return receipt requested,

 

15

 

facsimile, air courier guaranteeing
overnight delivery or personal delivery to the following addresses:

	 	(a)	 	If to GSO Crosstex Holdings LLC:

	 
	 	 	 	GSO Crosstex Holdings LLC

280 Park Avenue

New York, New York 10017

Attention: James Bennett, Marisa Beeney and Chris Sullivan

Facsimile: (212) 503-2157

Internet electronic mail: james.bennett@gsocap.com, maris.beeney@gsocap.com

or chris.sullivan@gsocap.com

	 
	 	 	 	with a copy to:

	 
	 	 	 	Andrews Kurth LLP

600 Travis, Suite 4200

Houston, Texas 77002

Attention: G. Michael O’Leary

Facsimile: (713) 238-7130

Internet electronic mail: moleary@akllp.com

	 
	 	(b)	 	If to Crosstex:

	 
	 	 	 	Crosstex Energy, L.P.

2501 Cedar Springs

Dallas, Texas 75201

Attention: General Counsel

Facsimile: (214) 721-9383

Internet electronic mail: joe.davis@crosstexenergy.com

	 
	 	 	 	with a copy to:

	 
	 	 	 	Baker Botts L.L.P.

2001 Ross Avenue

Dallas, Texas 75201-2980

Attention: Doug Rayburn

Facsimile: (214) 661-4634

Internet electronic mail: doug.rayburn@bakerbotts.com

or, if to a transferee of the Purchaser, to the transferee at the address provided pursuant to
Section 2.10 above. All notices and communications shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; upon actual receipt if sent by certified
or registered mail, return receipt requested, or regular mail, if mailed; upon actual receipt of
the facsimile copy, if sent via facsimile; and upon actual receipt when delivered to an air courier
guaranteeing overnight delivery.

 

16

 

Section 3.2 Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns
of each of the parties, including subsequent Holders of Registrable Securities to the extent
permitted herein.

Section 3.3 Assignment of Rights. All or any portion of the rights and obligations of the Purchaser under this Agreement may
be transferred or assigned by the Purchaser in accordance with Section 2.10 hereof.

Section 3.4 Recapitalization (Exchanges, etc. Affecting the Common Units). The provisions of this Agreement shall apply to the full extent set forth herein with
respect to any and all units of Crosstex or any successor or assign of Crosstex (whether by merger,
consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for or
in substitution of, the Registrable Securities, and shall be appropriately adjusted for
combinations, recapitalizations and the like occurring after the date of this Agreement.

Section 3.5 Specific Performance. Damages in the event of breach of this Agreement by a party hereto may be difficult, if not
impossible, to ascertain, and it is therefore agreed that each such Person, in addition to and
without limiting any other remedy or right it may have, will have the right to an injunction
or other equitable relief in any court of competent jurisdiction, enjoining any such breach, and
enforcing specifically the terms and provisions hereof, and each of the parties hereto hereby
waives any and all defenses it may have on the ground of lack of jurisdiction or competence of the
court to grant such an injunction or other equitable relief. The existence of this right will not
preclude any such Person from pursuing any other rights and remedies at law or in equity which such
Person may have.

Section 3.6 Counterparts. This Agreement may be executed in any number of counterparts and by different parties
hereto in separate counterparts, each of which counterparts, when so executed and delivered, shall
be deemed to be an original and all of which counterparts, taken together, shall constitute but one
and the same Agreement.

Section 3.7 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or
otherwise affect the meaning hereof.

Section 3.8 Governing Law, Submission to Jurisdiction. This Agreement, and all claims or causes of action (whether in contract or tort) that may
be based upon, arise out of or relate to this Agreement or the negotiation, execution or
performance of this Agreement (including any claim or cause of action based upon, arising out of or
related to any representation or warranty made in or in connection with this Agreement), will be
construed in accordance with and governed by the laws of the State of Delaware without regard to
principles of conflicts of laws. Any action against any party relating to the foregoing shall be
brought in any federal or state court of competent jurisdiction located within the State of
Delaware, and the parties hereto hereby irrevocably submit to the non-exclusive jurisdiction of any
federal or state court located within the State of Delaware over any such action. The parties
hereby irrevocably waive, to the fullest extent permitted by applicable Law, any objection which
they may now or hereafter have to the laying of venue of any such dispute brought in such court or
any defense of inconvenient forum for the maintenance of such dispute. Each of the parties hereto
agrees that a judgment in

 

17

 

 any such dispute may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by Law.

Section 3.9 Waiver of Jury Trial. THE PARTIES TO THIS AGREEMENT EACH HEREBY WAIVE, AND AGREE TO CAUSE THEIR AFFILIATES TO
WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND,
ACTION OR CAUSE OF ACTION (i) ARISING UNDER THIS AGREEMENT OR (ii) IN ANY WAY CONNECTED WITH OR
RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF
THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND
WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. THE PARTIES TO THIS AGREEMENT EACH HEREBY AGREES
AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT
TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OF A
COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO
THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

Section 3.10 Severability of Provisions. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction
shall, as to such jurisdiction, be ineffective to the extent of such prohibition or
unenforceability without invalidating the remaining provisions hereof or affecting or impairing the
validity or enforceability of such provision in any other jurisdiction.

Section 3.11 Entire Agreement. This Agreement and the Purchase Agreement are intended by the parties as a final expression
of their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein or therein.
There are no restrictions, promises, warranties or undertakings, other than those set forth or
referred to herein or therein with respect to the rights granted by Crosstex set forth herein or
therein. This Agreement, the Purchase Agreement and the Non-Disclosure Agreement supersede all
prior agreements and understandings between the parties with respect to such subject matter.

Section 3.12 Amendment. This Agreement may be amended only by means of a written amendment signed by Crosstex and
the Holders of a majority of the then outstanding Registrable Securities; provided,
however, that no such amendment shall adversely affect the rights of any Holder hereunder
without the consent of such Holder.

Section 3.13 No Presumption. In the event any claim is made by a party relating to any conflict, omission, or ambiguity
in this Agreement, no presumption or burden of proof or persuasion shall be implied by virtue of
the fact that this Agreement was prepared by or at the request of a particular party or its
counsel.

Section 3.14 Obligations Limited to Parties to Agreement. Each of the parties hereto covenants, agrees and acknowledges that no Person other than the
Purchaser, Selling Holders, their respective permitted assignees and Crosstex shall have any
obligation hereunder and that,

 

18

 

notwithstanding that one or more of Crosstex and the Purchaser may
be a corporation, partnership or limited liability company, no recourse under this Agreement or
under any documents or instruments delivered in connection herewith or therewith shall be had
against any former, current or future director, officer, employee, agent, general or limited
partner, manager, member, stockholder or Affiliate of any of Crosstex, the Purchaser, Selling
Holders or their respective permitted assignees, or any former, current or future director,
officer, employee, agent, general or limited partner, manager, member, stockholder or
Affiliate of any of the foregoing, whether by the enforcement of any assessment or by any legal or
equitable proceeding, or by virtue of any applicable law, it being expressly agreed and
acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise by
incurred by any former, current or future director, officer, employee, agent, general or limited
partner, manager, member, stockholder or Affiliate of any of Crosstex, the Purchaser, Selling
Holders or any of their respective assignees, or any former, current or future director, officer,
employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of
the foregoing, as such, for any obligations of Crosstex, the Purchaser, Selling Holders or their
respective permitted assignees under this Agreement or any documents or instruments delivered in
connection herewith or therewith or for any claim based on, in respect of or by reason of such
obligation or its creation, except in each case for any assignee of the Purchaser or a Selling
Holder hereunder.

Section 3.15 Interpretation. Article and Section references in this Agreement are references to the corresponding
Article and Section to this Agreement, unless otherwise specified. All references to instruments,
documents, contracts and agreements are references to such instruments, documents, contracts and
agreements as the same may be amended, supplemented and otherwise modified from time to time,
unless otherwise specified. The word “including” shall mean “including but not limited to.”
Whenever any determination, consent or approval is to be made or given by the Purchaser under this
Agreement, such action shall be in the Purchaser’s sole discretion unless otherwise specified.

 

19

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 
	 	 	CROSSTEX ENERGY, L.P.	 
	 
	 	 	 	 	 
	 	 	By: Crosstex Energy GP, L.P., its general partner	 
	 
	 	 	 	 	 
	 	 	By: Crosstex Energy GP, LLC, its general partner	 
	 
	 	 	 	 	 
	 

	 	By:	 	/s/ Joe A. Davis	 
	 

	 	 	 	 	 
	 

	 	 	 	Name:  Joe A. Davis	 
	 

	 	 	 	Title:  Executive Vice
President, General Counsel
          & Secretary	 

Signature Page to Registration Rights Agreement

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 	 	GSO CROSSTEX HOLDINGS LLC, by its Members	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	BLACKSTONE / GSO CAPITAL SOLUTIONS FUND LP	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:
	 	Blackstone / GSO Capital Solutions Associates LLC,	 	 
	 

	 	 	 	 	 	 	 	its General Partner	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:	 	/s/ George Fan	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	George Fan – Authorized Signatory	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	GSO CROSSTEX HOLDINGS (US) INC.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:	 	/s/ Marisa Beeney	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	Marisa Beeney – Authorized Signatory	 	 

Signature Page to Registration Rights Agreement

 

 

Schedule A

Purchaser

GSO Crosstex Holdings LLC

Schedule A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]